ArticleInvestigational new drugs2014

A multicenter phase 1 study of PX-866 and cetuximab in patients with metastatic colorectal carcinoma or recurrent/metastatic squamous cell carcinoma of the head and neck.

Daniel W Bowles et al.PubMed ↗Publisher ↗

No numbers read from the abstract.